Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease

被引:0
作者
Zhang S. [1 ,2 ]
Wang J. [1 ]
Lu J. [1 ]
Qi P. [1 ]
Hu S. [1 ]
Yang X. [1 ]
Chen K. [1 ]
Wang D. [1 ,2 ]
机构
[1] Department of Neurosurgery, Beijing Hospital, National Center of Gerontology, Dongcheng, Beijing
[2] Graduate School of Peking Union Medical College, Dongcheng, Beijing
关键词
Endovascular treatment; Follow-up; HRMRI; Intracranial atherosclerotic disease; Plaque characteristics;
D O I
10.1186/s41016-022-00302-3
中图分类号
学科分类号
摘要
Background: Endovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of EVT treatment on ICAD plaques is still unclear. This study describes the ICAD plaque characteristics after EVT treatment and analyzes the effect of different EVT treatments on plaque characteristics. Method: From 2017 January to 2022 January, ICAD patients who underwent endovascular treatment and had follow-up high-resolution magnetic resonance image (HRMRI) were enrolled in the study. Multiple plaque characteristics, including plaque enhancement, plaque burden, were measured based on preoperative, and follow-up HRMRI. Plaque characteristics and postoperative plaque changes were analyzed between different treatment groups. Result: Finally, 50 intracranial atherosclerotic plaques in 45 patients were included. Including 28 male patients and 17 female, media age 63.0 years old. Among 50 plaques, 41 received percutaneous angioplasty (including 22 plain balloons and 19 drug-coated balloons (DCB)) and the other 9 underwent stenting. Stenosis rate, plaque burden and eccentricity index at the lesion site were significantly decreased after EVT compared with preoperative periods (p <0.001). And only the DCB group showed a significant reduction in plaque enhancement at follow-up (p < 0.001). No significant preoperative and postoperative changes in other plaque characteristics were found. Conclusion: EVT treatment could compromise the characteristics of intracranial periarterial atherosclerotic plaques, and DCB treatment may result in a reduction in plaque enhancement after treatment. © 2022, The Author(s).
引用
收藏
相关论文
共 28 条
[1]  
Wong L.K., Global burden of intracranial atherosclerosis [J], Int J Stroke, 1, 3, pp. 158-159, (2006)
[2]  
Liu S., Luo Y., Wang C., Et al., Combination of plaque characteristics, pial collaterals, and hypertension contributes to misery perfusion in patients with symptomatic middle cerebral artery stenosis [J], J Magn Reson Imaging, 51, 1, pp. 195-204, (2020)
[3]  
Eskey C.J., Meyers P.M., Nguyen T.N., Et al., Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association [J], Circulation, 137, 21, pp. e661-e689, (2018)
[4]  
Wabnitz A., Chimowitz M., Angioplasty, stenting and other potential treatments of atherosclerotic stenosis of the intracranial arteries: past, present and future [J], J Stroke, 19, 3, pp. 271-276, (2017)
[5]  
Ma N., Zhang Y., Shuai J., Et al., Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study [J], Stroke Vasc Neurol, 3, 3, pp. 176-184, (2018)
[6]  
Ueda T., Takada T., Nogoshi S., Et al., Long-term outcome of balloon angioplasty without stenting for symptomatic middle cerebral artery stenosis [J], J Stroke Cerebrovasc Dis, 27, 7, pp. 1870-1877, (2018)
[7]  
Wojak J.C., Dunlap D.C., Hargrave K.R., Et al., Intracranial angioplasty and stenting: long-term results from a single center [J], AJNR Am J Neuroradiol, 27, 9, pp. 1882-1892, (2006)
[8]  
Chaabane C., Otsuka F., Virmani R., Et al., Biological responses in stented arteries [J], Cardiovasc Res, 99, 2, pp. 353-363, (2013)
[9]  
Han M., Rim N.J., Lee J.S., Et al., Feasibility of high-resolution MR imaging for the diagnosis of intracranial vertebrobasilar artery dissection [J], Eur Radiol, 24, 12, pp. 3017-3024, (2014)
[10]  
Zhang N., Liu X., Xiao J., Et al., Plaque morphologic quantification reliability of 3D whole-brain vessel wall imaging in patients with intracranial atherosclerotic disease: a comparison with conventional 3D targeted vessel wall imaging [J], J Magn Reson Imaging, 54, 1, pp. 166-174, (2021)